Health-related quality of life in women with newly diagnosed polycystic ovary syndrome randomized between clomifene citrate plus metformin or clomifene citrate plus placebo

What is the health-related quality of life (HRQoL) in women with polycystic ovary syndrome (PCOS) undergoing ovulation induction with clomifene citrate (CC) combined with metformin compared with those using CC combined with placebo?Overall quality of life in women with PCOS treated with CC plus metformin was significantly lower than in women treated with CC plus placebo.There are no data on HRQoL in adult women who receive ovulation induction...